RNF213 anticorps (N-Term)
Aperçu rapide pour RNF213 anticorps (N-Term) (ABIN928203)
Antigène
Voir toutes RNF213 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- KIAA1618 antibody was raised in rabbit using the N terminal of KIAA1618 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
KIAA1618 Blocking Peptide, (ABIN940030), is also available for use as a blocking control in assays to test for specificity of this KIAA1618 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- RNF213 (Ring Finger Protein 213 (RNF213))
-
Autre désignation
- KIAA1618
-
Sujet
- Translocation t(2,17)(p23,q25) with ALK, a chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma. Synonyms: Polyclonal KIAA1618 antibody, Anti-KIAA1618 antibody, KIAA1618 antibody.
Antigène
-